Patent directory · USPTO A61K / A61P
Patents matching “ONC”
274 pharma patents match "ONC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 274 pharmaceutical patents matching "ONC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11969435
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
granted -
US 11957677
Cancer treatment using FGFR inhibitors and PLK1 inhibitors
granted -
US 11944627
Methods for treating hematological malignancies and Ewing's sarcoma
granted -
US 11944617
Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4
granted -
WO 2024064327
OLIGOSACCHARIDES DE LAIT HUMAIN POUR AMÉLIORER LA FONCTION DE BARRIÈRE HÉMATO-ENCÉPHALIQUE
granted -
US 11884656
Pyrrole derivatives as PLK1 inhibitors
granted -
US 11865155
Plant extract obtained from Morus plant leaves which has an IC50 value to inhibit a-glucosidase I at a concentration of less than 90 uG/ml, compositions containing same, method of extraction and uses thereof
granted -
US 11786524
Pharmaceutical compounds
granted -
US 11760803
Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments
granted -
US 11752184
Bioactive concentrates and uses thereof
granted -
US 11672774
Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors
granted -
US 11655455
Enhanced systems for cell-mediated oncolytic viral therapy
granted -
US 11649251
Substituted inhibitors of menin-MLL and methods of use
granted -
US 11622977
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11607426
Method of targeting oncolytic viruses to tumors
granted -
US 11596660
Methods of treating bladder cancer
granted -
US 11590184
Oncolytic rhabdovirus expressing IL12
granted -
US 11541125
Noncrushable pill formulations
granted -
US 11541045
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 11542526
Oncolytic adenoviral vector and methods of use
granted -
US 11497781
Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor
granted -
WO 2022226311
COMPOSITIONS NUTRITIONNELLES COMPRENANT DES OLIGOSACCHARIDES DE LAIT HUMAIN ET UN CONSTITUANT LIPIDIQUE DÉSIGNÉ D'AMÉLIORATION DE FONCTION PULMONAIRE
granted -
US 11471491
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11433038
High concentration medicant solutions for treating neurological disorders
granted